|
Name |
(Z)-beta-Ocimene epoxide
|
| Molecular Formula | C10H16O | |
| IUPAC Name* |
2,2-dimethyl-3-[(2Z)-3-methylpenta-2,4-dienyl]oxirane
|
|
| SMILES |
C/C(=C/CC1C(O1)(C)C)/C=C
|
|
| InChI |
InChI=1S/C10H16O/c1-5-8(2)6-7-9-10(3,4)11-9/h5-6,9H,1,7H2,2-4H3/b8-6-
|
|
| InChIKey |
LIMXJCIGROLRED-VURMDHGXSA-N
|
|
| Synonyms |
cis-Myroxide; (Z)-Myroxide; (Z)-beta-Ocimene epoxide; (Z)-6,7-Epoxyocimene; (Z)-.beta.-Ocimene epoxide; 4L6651QT3T; 1,3-Octadiene, 6,7-epoxy-3,7-dimethyl-, (Z)-; 33281-83-3; 2,2-Dimethyl-3-((2Z)-3-methyl-2,4-pentadien-1-yl)oxirane; Oxirane, 2,2-dimethyl-3-((2Z)-3-methyl-2,4-pentadien-1-yl)-; beta-Ocimene epoxide, (Z)-; Oxirane, 2,2-dimethyl-3-[(2Z)-3-methyl-2,4-pentadien-1-yl]-; UNII-4L6651QT3T; .BETA.-OCIMENE EPOXIDE, (Z)-; Q27896140; (Z)-2,2-Dimethyl-3-(3-methylpenta-2,4-dien-1-yl)oxirane; Oxirane, 2,2-dimethyl-3-(3-methyl-2,4-pentadienyl)-, (Z)-; Oxirane, 2,2-dimethyl-3-[(2Z)-3-methyl-2,4-pentadienyl]-
|
|
| CAS | 33281-83-3 | |
| PubChem CID | 14701631 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 152.23 | ALogp: | 2.9 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 12.5 | Aromatic Rings: | 1 |
| Heavy Atoms: | 11 | QED Weighted: | 0.445 |
| Caco-2 Permeability: | -4.272 | MDCK Permeability: | 0.00002500 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.002 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.925 | Plasma Protein Binding (PPB): | 81.92% |
| Volume Distribution (VD): | 1.543 | Fu: | 9.72% |
| CYP1A2-inhibitor: | 0.103 | CYP1A2-substrate: | 0.16 |
| CYP2C19-inhibitor: | 0.063 | CYP2C19-substrate: | 0.863 |
| CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.068 |
| CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.302 |
| CYP3A4-inhibitor: | 0.042 | CYP3A4-substrate: | 0.375 |
| Clearance (CL): | 10.689 | Half-life (T1/2): | 0.562 |
| hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.502 |
| Drug-inuced Liver Injury (DILI): | 0.108 | AMES Toxicity: | 0.09 |
| Rat Oral Acute Toxicity: | 0.05 | Maximum Recommended Daily Dose: | 0.373 |
| Skin Sensitization: | 0.31 | Carcinogencity: | 0.858 |
| Eye Corrosion: | 0.923 | Eye Irritation: | 0.977 |
| Respiratory Toxicity: | 0.965 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000526 | ![]() |
0.385 | D0H6VY | ![]() |
0.280 | ||
| ENC001568 | ![]() |
0.385 | D0S7WX | ![]() |
0.181 | ||
| ENC003102 | ![]() |
0.333 | D0M1PQ | ![]() |
0.174 | ||
| ENC000847 | ![]() |
0.308 | D0FG6M | ![]() |
0.167 | ||
| ENC001735 | ![]() |
0.302 | D0U4VT | ![]() |
0.152 | ||
| ENC001734 | ![]() |
0.302 | D0W6DG | ![]() |
0.147 | ||
| ENC004455 | ![]() |
0.297 | D02DGU | ![]() |
0.145 | ||
| ENC001664 | ![]() |
0.283 | D0G3PI | ![]() |
0.145 | ||
| ENC001564 | ![]() |
0.283 | D00DKK | ![]() |
0.145 | ||
| ENC001566 | ![]() |
0.268 | D09JBP | ![]() |
0.143 | ||